Boudewijn J. Van Etten

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Roux-en-Y Reconstruction After Esophagectomy for Postoperative Functional Complaints: A Case Series.

Roux-en-Y Reconstruction After Esophagectomy for Postoperative Functional Complaints: A Case Series.

Journal: ANZ journal of surgery

Published: July 31, 2026

Explaining increased locoregional failure following total neoadjuvant treatment in RAPIDO.

Explaining increased locoregional failure following total neoadjuvant treatment in RAPIDO.

Journal: The British journal of surgery

Published: July 15, 2026

Regional characteristics of esophageal cancer and robot-assisted minimally invasive esophagectomy (RAMIE): an analysis of the international UGIRA registry.

Regional characteristics of esophageal cancer and robot-assisted minimally invasive esophagectomy (RAMIE): an analysis of the international UGIRA registry.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: January 29, 2026

Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer.

Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 10, 2025

The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer.

The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer.

Journal: Clinical and translational radiation oncology

Published: December 10, 2025

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

Journal: International journal of radiation oncology, biology, physics

Published: November 26, 2025

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

Journal: The Lancet. Oncology

Published: November 20, 2025

[18F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).

[18F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).

Journal: BMC cancer

Published: October 09, 2025

Using a composite end-point and WIN-ratio analysis to evaluate perineal wound healing after abdominoperineal resection for rectal cancer: further insights from the BIOPEX trials.

Using a composite end-point and WIN-ratio analysis to evaluate perineal wound healing after abdominoperineal resection for rectal cancer: further insights from the BIOPEX trials.

Journal: International journal of surgery (London, England)

Published: August 12, 2025

Metastatic mismatch repair deficient oesophageal squamous cell carcinoma leading to diagnosis of Lynch syndrome with a complete response to nivolumab treatment.

Metastatic mismatch repair deficient oesophageal squamous cell carcinoma leading to diagnosis of Lynch syndrome with a complete response to nivolumab treatment.

Journal: Virchows Archiv : an international journal of pathology

Published: August 04, 2025

Feasibility of intraluminal oxygen delivery after minimally invasive esophagus resection.

Feasibility of intraluminal oxygen delivery after minimally invasive esophagus resection.

Journal: Surgery open science

Published: July 23, 2025

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

Journal: The British journal of surgery

Published: May 09, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026